Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease - Perspectives from the CREDO-Kyoto Registry

Circulation Journal

Volumn 72, Issue 12, 2008, Pages 1937-1945

  Furukawa, Yutaka ^a,c   Taniguchi, Ryoji ^b   Ehara, Natsuhiko ^a   Ozasa, Neiko ^c   Haruna, Yoshisumi ^d   Saito, Naritatsu ^c   Doi, Takahiro ^c   Hoshino, Kozo ^e   Shizuta, Satoshi ^c   Morimoto, Takeshi ^f   Imai, Yukiko ^g   Teramukai, Satoshi ^g,t   Fukushima, Masanori ^g,t   Kita, Toru ^c   Kimura, Takeshi ^c   Lee, Jong Dae ^h   Tanaka, Kuniyoshi ^h   Okazaki, Katsuo ⁱ   Takahashi, Masaaki ^j   Oda, Teiji ^j   Matsui, Shigeo ^k   Ohashi, Naohiro ^k   Matsuyama, Eiichi ^l   Kadoya, Makoto ^l   Takatsu, Yoshiki ^m   Nomoto, Shinichi ^m   Kataoka, Kazuaki ^m   Kotoura, Hajime ⁿ   Aota, Masaki ⁿ   Miura, Akira ⁿ   Suwa, Satoru ^o   Tei, Chuwa ^p   Sakata, Ryuzo ^p   Hamasaki, Shuichi ^p   Yamamoto, Hiroyuki ^p   Aoyama, Takeshi ^q   Sakurai, Takahiro ^q   Matsuda, Mitsuo ^r   Onoe, Masahiko ^r   Takeuchi, Yuzo ^r   Nohara, Ryuji ^s   Nakano, Kimisato ^s   Morioka, Shigefumi ^a   Okada, Yukikatsu ^a   Shiratori, Kenichi ^a   Kihara, Yasuki ^a   Nasu, Michihiro ^a   Nobuyoshi, Masakiyo ^u   Okabayashi, Hitoshi ^u   Yasumoto, Hitoshi ^u   Nakano, Jyota ^u   Murakami, Tomoyuki ^v   Ishida, Katsuya ^v   Ogawa, Hisao ^w   Kawasuji, Michio ^w   Sugiyama, Seigo ^w   Hagiwara, Shoichiro ^w   Mitsudo, Kazuaki ^x   Komiya, Tatsuhiko ^x   Kadota, Kazushige ^x   Komeda, Masashi ^c   Tatami, Ryozo ^y   Ushijima, Teruaki ^y   Yoshida, Akira ^z   Nakajima, Hiroyuki ^z   Miki, Shinji ^z   Hattori, Ryuichi ^aa   Nishiwaki, Noboru ^aa   Shirotani, Manabu ^aa   Kato, Hiroshi ^ab   Eizawa, Hiroshi ^ab   Tanaka, Masaru ^ac   Minami, Kazuaki ^ac   Horie, Minoru ^ad   Asai, Tohru ^ad   Takashima, Hiroyuki ^ad   Higashita, Ryuji ^ad   Takahashi, Mamoru ^ae   Tahata, Takafumi ^ae   Matoba, Yoshiki ^ae   Doyama, Kiyoshi ^af   Araki, Makoto ^af   Takizawa, Akinori ^ag   Shimamoto, Mitsuomi ^ag   Yamazaki, Fumio ^ag   Doi, Osamu ^ah   Kambara, Hirofumi ^ah   Matsuda, Katsuhiko ^ah   Kaburagi, Satoshi ^ah   Nara, Masafumi ^ah   Kawanami, Masaki ^ai   Konishi, Takashi ^aj   Nishimura, Kazunobu ^aj   Ootani, Seiji ^aj   Sugita, Takaaki ^aj   more..

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d Hirakata Kohsai Hospital   (Japan)

^e Nagai Hospital   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Translational Research Informatics Center   (Japan)

^h UNIVERSITY OF FUKUI HOSPITAL   (Japan)

ⁱ Fukuroi Municipal Hospital

^j HAMAMATSU ROSAI HOSPITAL   (Japan)

^k Hikone Municipal Hospital

^l NATIONAL HOSPITAL ORGANIZATION HIMEJI MEDICAL CENTER   (Japan)

^m Hyogo Prefectural Amagasaki Hospital   (Japan)

ⁿ JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^o JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^p KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^q KANSAI ELECTRIC POWER CO   (Japan)

^r Kishiwada City Hospital

^s Kitano Hospital   (Japan)

^t Translational Research Informatics Center

^u Kokura Memorial Hospital

^v Koto Memorial Hospital

^w KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^x KURASHIKI CENTRAL HOSPITAL   (Japan)

^y Maizuru Kyosai Hospital

^z MITSUBISHI KYOTO HOSPITAL   (Japan)

^aa KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

^ab NISHI KOBE MEDICAL CENTER   (Japan)

^ac OSAKA RED CROSS HOSPITAL   (Japan)

^ad SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

^ae Shimabara Hospital

^af Shimada Municipal Hospital

^ag SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^ah SHIZUOKA GENERAL HOSPITAL   (Japan)

^ai Shizuoka City Shizuoka Hospital ^*

^aj TENRI HOSPITAL   (Japan)

more..

Author keywords

Coronary artery disease; Mortality; Revascularization; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TICLOPIDINE;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; JAPANESE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 56849126602     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0293     Document Type: Article

References (36)

1. Prasad A, Reeder G. Modern adjunctive pharmacotherapy of myocardial infarction. Expert Opin Pharmacother 2000; 1: 405-418.
2. Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, et al. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med 2006; 144: 229-238.
3. Group SSSS. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
4. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.
5. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
6. Investigators TPCABGT. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts: The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997; 336: 153-162.
7. Group TL-TIwPiIDLS. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
8. Flaker GC, Warnica JW, Sacks FM, Moye LA, Davis BR, Rouleau JL, et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations: Cholesterol and Recurrent Events (CARE) Investigators. J Am Coll Cardiol 1999; 34: 106-112.
9. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
10. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 2004; 110: 386-391.
11. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
12. Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial. JAMA 2002; 287: 3215-3222.
13. Arora R, Sowers JR, Saunders E, Probstfield J, Lazar HL. Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery. J Card Surg 2006; 21: 198-204.
14. Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, et al. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: Analysis of the Treating to New Targets study. Lancet 2006; 368: 919-928.
15. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial. Lancet 2006; 368: 1155-1163.
16. Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, et al. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 2006; 97: 1165-1171.
17. Sato H, Kinjo K, Ito H, Hirayama A, Nanto S, Fukunami M, et al. Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACIS-LIPID Study. Circ J 2008; 72: 17-22.
18. Nagashima M, Koyanagi R, Kasanuki H, Hagiwara N, Yamaguchi J, Atsuchi N, et al. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program). Am J Cardiol 2007; 99: 1523-1528.
19. Kohro T, Hayashi D, Okada Y, Yamazaki T, Nagai R. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 2007; 71: 1835-1840.
20. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation 2008; 118(Suppl): S199-S209.
21. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
22. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127: 757-763.
23. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
24. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004; 109: 2290-2295.
25. Sekikawa A, Satoh T, Hayakawa T, Ueshima H, Kuller LH. Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by state in the United States in 1995-1998: Vital statistics data in recent birth cohort. Jpn Circ J 2001; 65: 887-892.
26. Sekikawa A, Ueshima H, Kadowaki T, El-Saed A, Okamura T, Takamiya T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 2007; 165: 617-624.
27. Schomig A, Mehilli J, Holle H, Hosl K, Kastrati D, Pache J, et al. Statin treatment following coronary artery stenting and one-year survival. J Am Coll Cardiol 2002; 40: 854-861.
28. Fox DJ, Kibiro M, Eichhofer J, Curzen NP. Patients undergoing coronary revascularisation: A missed opportunity for secondary prevention? Postgrad Med J 2005; 81: 401-403.
29. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004; 110: 674-678.
30. Kinoshita M, Matsumura S, Sueyoshi K, Ogawa S, Fukuda K. Randomized trial of statin administration for myocardial injury: Is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention? Circ J 2007; 71: 1225-1228.
31. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004; 110(Suppl): II-45-II-49.
32. Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005; 96: 611-616.
33. Shook SJ, Gupta R, Vora NA, Tievsky AL, Katzan I, Krieger DW. Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging 2006; 16: 341-346.
34. Alvarez-Sabin J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribo M, et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007; 38: 1076-1078.
35. Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 2005; 26: 1011-1022.
36. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.